GILD Gilead Sciences PE ratio, current and historical analysis
As of Oct 29, 2024, the Gilead Sciences stock's PE ratio is 103.61. This results from the current EPS of $0.85 and stock price of $88.07. The P/E ratio has an increase of 39% from the past four quarters average of 74.4.
GILD PE ratio history
The PE ratio of Gilead Sciences has averaged 45.49 over the last ten years. The current PE ratio of 103.61 is 128% above the historical average. Over the past ten years, GILD's PE ratio was at its highest in the Dec 2020 quarter at 582.6, when the stock price was $58.26 and the EPS was $0.1. The lowest value was in the Dec 2016 quarter, when it reached 7.1 with a price of $71.61 and an EPS of $10.08.
Gilead Sciences PE ratio by year
Maximum annual increase: 3,700.39% in 2020
Maximum annual decrease: -97.49% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 17.84 | -23.96% |
| 2022 | 23.46 | 60.25% |
| 2021 | 14.64 | -97.49% |
| 2020 | 582.6 | 3,700.39% |
| 2019 | 15.33 | 2.96% |
| 2018 | 14.89 | -26.43% |
| 2017 | 20.24 | 185.07% |
| 2016 | 7.1 | -13.2% |
| 2015 | 8.18 | -31.03% |
| 2014 | 11.86 | -68.25% |
GILD average PE ratio chart
The current PE ratio of GILD is greater than its 3, 5 and 10-year historical averages.
GILD PE vs peers
Compared to its peers LLY and QGEN, GILD's PE ratio stands lower, however it is higher than JNJ's and ABBV's. Gilead Sciences's PE ratio is trading above the peer group average of 37.19.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MRK Merck & Co Inc | 19.21 | $263.37B |
| BIIB Biogen Inc | 22.8 | $26.47B |
| JNJ Johnson & Johnson | 26.62 | $386.5B |
| AMGN Amgen Inc | 53.93 | $169.52B |
| ABBV AbbVie Inc | 66.21 | $350.85B |
| LLY ELI LILLY & Co | 102.62 | $794.92B |
| GILD Gilead Sciences Inc | 103.71 | $109.75B |
| QGEN Qiagen NV | 151.07 | $9.47B |
| VRTX Vertex Pharmaceuticals Inc | N/A | $122.44B |
| ILMN Illumina Inc | N/A | $23.43B |
| PFE Pfizer Inc | N/A | $160.31B |
Frequently asked questions
What is Gilead Sciences's PE ratio?
GILD stock has a price to earnings ratio of 103.61 as of Oct 29, 2024.
What is the 3-year average PE ratio for Gilead Sciences (GILD)?
Over the last 3 years, the average price to earnings ratio for GILD stock is 39.11.
What is the 5-year average PE ratio for Gilead Sciences (GILD)?
Over the last 5 years, the average price to earnings ratio for GILD stock is 77.71.
What is the highest PE ratio for GILD?
In the last ten years, the Dec 2020 quarter recorded the highest quarterly PE ratio at 582.6.
How does the current PE ratio for GILD compare to its historical average?
GILD's price to earnings ratio is currently 128% above its 10-year historical average.
Why is Gilead Sciences's PE ratio so high?
A company with a higher PE ratio may indicate that the market has higher growth expectations for the company's future earnings or profitability.
How is GILD's PE ratio calculated (Gilead Sciences PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Oct 29, 2024), Gilead Sciences's stock price is $88.07. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.85. Therefore, Gilead Sciences's P/E ratio for today is 103.61. PE RATIO(103.61) = STOCK PRICE($88.07) / TTM EPS($0.85)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.